Drugs / autologous adipose tissue derived mesenchymal stem cells
autologous adipose tissue derived mesenchymal stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01624779 | Apr 2012 → May 2014 | spinal cord injury | Bukwang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous adipose tissue derived mesenchymal stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01624779 ↗ |
| Modality | Cell therapy | “autologous adipose tissue derived mesenchymal stem cells” NCT01624779 ↗ |
| Route | Intrathecal | “Intrathecal Transplantation” NCT01624779 ↗ |